
Sign up to save your podcasts
Or


CEO Larry Edwards describes the unmet need in the immunocompromised space, and highlights Aicuris' commercial CMV product (PREVYMIS), partnered with Merck/MSD, and R&D products targeting HSV and BKV.
By BiotechTV4.3
66 ratings
CEO Larry Edwards describes the unmet need in the immunocompromised space, and highlights Aicuris' commercial CMV product (PREVYMIS), partnered with Merck/MSD, and R&D products targeting HSV and BKV.

3,223 Listeners

1,902 Listeners

123 Listeners

324 Listeners

61 Listeners

9,960 Listeners

86 Listeners

34 Listeners

353 Listeners

19 Listeners

60 Listeners

514 Listeners

41 Listeners

0 Listeners

4 Listeners

2 Listeners

6 Listeners

46 Listeners